How humans continuously adapt while walking stably

byMassachusetts Institute of TechnologyA hierarchical framework for locomotor adaptation. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53416-wResearchers have develope

Updated on: January 15,2025

How humans continuously adapt while walking stably

byMassachusetts Institute of TechnologyA hierarchical framework for locomotor adaptation. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53416-wResearchers have develope

Updated on:January 15,2025

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st

Updated on: April 25,2024

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer's disease

by University of Eastern FinlandCredit: CC0 Public DomainOpioid analgesics were associated with a 30 percent increase in the risk of pneumonia in persons with Alzheimer's disease, a recent st

Updated on:April 25,2024

The construction of visual attention highlighted at the neuronal level

byParis Brain InstituteAttention being caught. Credit: Mikhail Nilov.A giant billboard flashes on the side of a country road. Why does it catch our attention more easily than other details in th

Updated on: March 28,2024

The construction of visual attention highlighted at the neuronal level

byParis Brain InstituteAttention being caught. Credit: Mikhail Nilov.A giant billboard flashes on the side of a country road. Why does it catch our attention more easily than other details in th

Updated on:March 28,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on: April 16,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on:April 16,2024

Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

by Caroline Graff and Charlotte Johansson,The ConversationCredit: AI-generated imageThough Alzheimer's disease affects more than55 million people worldwide, there's still no cure f

Updated on: April 16,2024

Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

by Caroline Graff and Charlotte Johansson,The ConversationCredit: AI-generated imageThough Alzheimer's disease affects more than55 million people worldwide, there's still no cure f

Updated on:April 16,2024

Immune cells in the brain play key role in relationship between gut microbes and b-amyloid deposits

by University of Chicago Medical CenterMicroglia in the brain of male mice with Alzheimer's Disease have a “neurodegenerative” appearance and is associated with amyloid beta plaques in the br

Updated on: May 18,2024

Immune cells in the brain play key role in relationship between gut microbes and b-amyloid deposits

by University of Chicago Medical CenterMicroglia in the brain of male mice with Alzheimer's Disease have a “neurodegenerative” appearance and is associated with amyloid beta plaques in the br

Updated on:May 18,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on: March 02,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on:March 02,2024

From Alzheimer's to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases

by Ellen Goldbaum,University at BuffaloImage of glucose metabolism PET overlaid on CT in an Alzheimer's patient with mild dementia. Green arrow points to regional hypometabolism in the media

Updated on: May 13,2024

From Alzheimer's to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases

by Ellen Goldbaum,University at BuffaloImage of glucose metabolism PET overlaid on CT in an Alzheimer's patient with mild dementia. Green arrow points to regional hypometabolism in the media

Updated on:May 13,2024

Alzheimer's study: Electrostimulation to evoke vivid memories

by Wissam Deeb,The ConversationThe fornix, a tiny part of the brain, may hold some clues to memory loss. Credit: Wissam Deeb, CC BY-SAAlzheimer's diseaseis one of the most dreaded diag

Updated on: April 20,2024

Alzheimer's study: Electrostimulation to evoke vivid memories

by Wissam Deeb,The ConversationThe fornix, a tiny part of the brain, may hold some clues to memory loss. Credit: Wissam Deeb, CC BY-SAAlzheimer's diseaseis one of the most dreaded diag

Updated on:April 20,2024

Machine learning gives nuanced view of Alzheimer's stages

by David Nutt,Cornell UniversityFeed-forward, fully-connected neural network architecture. Nonlinear models have rectified linear units (ReLU) between layers. Final layer implements a soft-max.

Updated on: June 14,2024

Machine learning gives nuanced view of Alzheimer's stages

by David Nutt,Cornell UniversityFeed-forward, fully-connected neural network architecture. Nonlinear models have rectified linear units (ReLU) between layers. Final layer implements a soft-max.

Updated on:June 14,2024

New research uncovers brain changes in Parkinson's disease

Updated on: March 09,2025

New research uncovers brain changes in Parkinson's disease

Updated on:March 09,2025

No new drugs for Alzheimer's disease in 15 years

by Vanessa Jane Hall,ScienceNordicCredit: AI-generated imageHow often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?The answer is probably

Updated on: March 13,2024

No new drugs for Alzheimer's disease in 15 years

by Vanessa Jane Hall,ScienceNordicCredit: AI-generated imageHow often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?The answer is probably

Updated on:March 13,2024